US 10052382
Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10052382 (Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides) held by The United States of America as Represented by the Secretary of Health (NIH) expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of Health (NIH)
- Grant date
- Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39558, A61K47/68